🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery

Chai Discovery, which develops AI tools for molecular design, is building design software alongside its pharmaceutical partners. The episode introduction describes a molecule editor closer to a CAD or graphics design program than a chatbot, and an ambition to produce better initial candidates that need less laboratory work and fewer iterations.

Its product lead describes pharmaceutical partners' requests as inputs to the research agenda. That makes the partnerships a way to learn which design capabilities scientists need, alongside selling access to the technology. The account explains Chai's product-development strategy without establishing that its proposed molecules will succeed in clinical trials.